n-Butyrate % Test

n-Butyrate (also called butyric acid) is a short-chain fatty acid (SCFA) produced when gut bacteria ferment dietary fiber. It serves as the main energy source for colon cells and plays a critical role in maintaining gut barrier integrity, regulating inflammation, and influencing whole-body metabolism. Measuring n-butyrate as a percentage of total SCFAs helps assess gut microbial function and overall intestinal health.

n-Butyrate is primarily produced by beneficial anaerobic bacteria in the colon, particularly Faecalibacterium prausnitzii, Eubacterium rectale, and Roseburia species, through the fermentation of indigestible carbohydrates like resistant starch, inulin, and certain fibers. Once formed, butyrate nourishes colonocytes (the cells lining the colon), promotes mucus production, and strengthens the tight junctions that keep the intestinal barrier intact. A well-sealed barrier prevents harmful bacterial products such as lipopolysaccharides (LPS) from leaking into circulation, a process often called “metabolic endotoxemia,” which contributes to systemic inflammation and insulin resistance.

Beyond its local effects in the gut, butyrate acts as an epigenetic regulator. It inhibits histone deacetylases (HDACs), enzymes that modify gene expression. Through this mechanism, butyrate suppresses inflammatory pathways, enhances oxidative metabolism, and improves insulin sensitivity in animal and human studies. For instance, diets supplemented with 0.5-5% sodium butyrate in rodents have been shown to reduce intestinal inflammation, prevent obesity, and improve glucose control.

When Levels Are Low or High

Low fecal butyrate or a low n-butyrate percentage suggests reduced production by the microbiome, often seen in people with inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), or diets low in fermentable fiber. Chronic low butyrate production can weaken the gut barrier and promote inflammation. Conversely, elevated butyrate levels, though less common, may occur during high-fiber diets or in individuals with rapid fermentation, and are generally considered beneficial unless accompanied by other dysbiotic patterns.

Clinical Relevance

Because butyrate reflects both microbial composition and host health, its measurement in stool provides insight into the metabolic performance of the gut ecosystem. Restoring butyrate-producing bacteria, through dietary fiber, resistant starch, or probiotic interventions, has been shown to enhance gut barrier function and modulate systemic inflammation. These effects make butyrate a cornerstone molecule linking gut health with metabolic resilience, longevity, and disease prevention.